Elicio Therapeutics (ELTX) Other Working Capital Changes (2020 - 2025)
Elicio Therapeutics posted quarterly Other Working Capital Changes of $142000.0 for Q4 2025, up 167.94% year-on-year from $52996.4 in Q4 2024, and up 12.7% on a QoQ basis from $126000.0 in Q3 2025.
Elicio Therapeutics (ELTX) has 6 years of Other Working Capital Changes data on file, last reported at $142000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes rose 167.94% year-over-year to $142000.0; the trailing twelve-month figure through Mar 2026 stood at -$905000.0 (down 608.43% YoY), and the FY2025 full-year result was -$901000.0, up 1.1% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at $142000.0, up from $126000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.7 million in Q3 2022 and bottomed at -$2.0 million in Q4 2022.
- The 5-year median for Other Working Capital Changes is -$223000.0 (2023), against an average of -$215833.3.
- Peak annual rise in Other Working Capital Changes reached 443.28% in 2022, while the deepest fall reached 889.37% in 2022.
- A 5-year view of Other Working Capital Changes shows it stood at -$207000.0 in 2021, then slumped by 889.37% to -$2.0 million in 2022, then jumped by 88.43% to -$237000.0 in 2023, then gained by 11.81% to -$209000.0 in 2024, then soared by 167.94% to $142000.0 in 2025.
- The last three Other Working Capital Changes figures came in at $142000.0 (Q4 2025), $126000.0 (Q3 2025), and -$1.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 142,000.00 |
| Dec 31, 2025 | 142,000.00 |
| Sep 30, 2025 | 126,000.00 |
| Sep 30, 2025 | 126,000.00 |
| Jun 30, 2025 | -1.17 Mn |
| Jun 30, 2025 | -1.17 Mn |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | -209,000.00 |
| Dec 31, 2024 | -209,000.00 |
| Sep 30, 2024 | -358,000.00 |
| Sep 30, 2024 | -358,000.00 |
| Jun 30, 2024 | 741,000.00 |
| Jun 30, 2024 | 741,000.00 |
| Mar 31, 2024 | -1.09 Mn |
| Mar 31, 2024 | -1.09 Mn |
| Dec 31, 2023 | -237,000.00 |
| Dec 31, 2023 | -237,000.00 |
| Sep 30, 2023 | -251,000.00 |
| Sep 30, 2023 | -251,000.00 |
| Jun 30, 2023 | 170,000.00 |
| Jun 30, 2023 | 170,000.00 |
| Mar 31, 2023 | -507,000.00 |
| Mar 31, 2023 | -507,000.00 |
| Dec 31, 2022 | -2.05 Mn |
| Dec 31, 2022 | -2.05 Mn |
| Sep 30, 2022 | 1.74 Mn |
| Sep 30, 2022 | 1.74 Mn |
| Jun 30, 2022 | 1.42 Mn |
| Jun 30, 2022 | 1.42 Mn |
| Mar 31, 2022 | -1.65 Mn |
| Mar 31, 2022 | -1.65 Mn |
| Dec 31, 2021 | -207,000.00 |
| Dec 31, 2021 | -207,000.00 |
| Sep 30, 2021 | -506,000.00 |
| Sep 30, 2021 | -506,000.00 |
| Dec 31, 2020 | -3.13 Mn |
| Dec 31, 2020 | -3.13 Mn |
| Sep 30, 2020 | 2.57 Mn |
| Sep 30, 2020 | 2.57 Mn |
| Jun 30, 2020 | 152,000.00 |
| Jun 30, 2020 | 152,000.00 |
| Mar 31, 2020 | -152,000.00 |
| Mar 31, 2020 | -152,000.00 |